Clinical Trial Update: Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial examining endogenous GLP-1 secretion and its effect on islet function in healthy individuals and those with Type 2 diabetes has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Adrian Vella | Conditions: Healthy, Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2023-12-26